Pulse Biosciences, Inc (PLSE) financial statements (2021 and earlier)

Company profile

Business Address 3957 POINT EDEN WAY
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7513816
Cash and cash equivalents75132
Short-term investments  3514
Other undisclosed current assets20900
Total current assets:26603817
Noncurrent Assets
Operating lease, right-of-use asset5
Property, plant and equipment3230
Intangible assets, net (including goodwill)7899
Goodwill3333
Intangible assets, net (excluding goodwill)5567
Other noncurrent assets000 
Total noncurrent assets:16101110
TOTAL ASSETS:42715026
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4321
Accounts payable2110
Accrued liabilities2111
Deferred rent credit 0
Deferred revenue and credits0 
Total current liabilities:4321
Noncurrent Liabilities
Long-term debt and lease obligation7   
Operating lease, liability7
Liabilities, other than long-term debt 12 
Deferred revenue and credits2 
Deferred rent credit 1
Total noncurrent liabilities:712 
Total liabilities:11441
Stockholders' equity
Stockholders' equity attributable to parent31664625
Common stock0000
Additional paid in capital1531428438
Accumulated other comprehensive income (loss)0(0)(0)(0)
Accumulated deficit(123)(76)(38)(13)
Total stockholders' equity:31664625
TOTAL LIABILITIES AND EQUITY:42715026

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues
(Net Investment Income)
1000
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)
Gross profit:0(0)(1)(0)
Operating expenses(48)(38)(26)(10)
Other undisclosed operating income1111
Operating loss:(47)(38)(26)(10)
Net loss available to common stockholders, diluted:(47)(38)(26)(10)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(47)(38)(26)(10)
Comprehensive loss:(47)(38)(26)(10)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)(0)
Comprehensive loss, net of tax, attributable to parent:(47)(37)(26)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: